Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Rusthoven

Showing results (41-50 of 69) with videos related to

Pageof 7
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1985
Combination chemotherapy with bleomycin, etoposide, and cisplatin in metastatic non-small-cell lung cancerD Osoba, J J Rusthoven, K A Turnbull, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 8, 1998
The impact of postchemotherapy nausea and vomiting on quality of life after moderately emetogenic chemotherapyJ J Rusthoven, D Osoba, C A Butts, et al.
Cancer Chemotherapy and Pharmacology|December 3, 2005
A semimechanistic-physiologic population pharmacokinetic/pharmacodynamic model for neutropenia following pemetrexed therapyJane E Latz, Mats O Karlsson, James J Rusthoven, et al.
Cancer Chemotherapy and Pharmacology|December 3, 2005
Clinical application of a semimechanistic-physiologic population PK/PD model for neutropenia following pemetrexed therapyJane E Latz, James J Rusthoven, Mats O Karlsson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Multitargeted antifolate LY231514 as first-line chemotherapy for patients with advanced non-small-cell lung cancer: A phase II study. National Cancer Institute of Canada Clinical Trials GroupJ J Rusthoven, E Eisenhauer, C Butts, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|August 1, 1993
Impact of chemotherapy-associated nausea and vomiting on patients' functional status and on costs: survey of five Canadian centresB J O'Brien, J Rusthoven, A Rocchi, et al.
Cancer|July 27, 2004
Adapting the Lung Cancer Symptom Scale (LCSS) to mesothelioma: using the LCSS-Meso conceptual model for validationPatricia J Hollen, Richard J Gralla, Astra M Liepa, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 7, 2005
Measuring quality of life in patients with pleural mesothelioma using a modified version of the Lung Cancer Symptom Scale (LCSS): psychometric properties of the LCSS-MesoPatricia J Hollen, Richard J Gralla, Astra M Liepa, et al.
Archives of Internal Medicine|July 1, 1988
Varicella-zoster infection in adult cancer patients. A population studyJ J Rusthoven, P Ahlgren, T Elhakim, et al.
International Journal of Antimicrobial Agents|May 1, 1997
Consensus on the use of neutrophil-stimulating hematopoietic growth factors in clinical practice: an international viewpointJ J Rusthoven, E G de Vries, D C Dale, et al.
Pageof 7

Showing results (41-50 of 69) with videos related to

Sort By:
Pageof 7
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1985
Combination chemotherapy with bleomycin, etoposide, and cisplatin in metastatic non-small-cell lung cancerD Osoba, J J Rusthoven, K A Turnbull, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 8, 1998
The impact of postchemotherapy nausea and vomiting on quality of life after moderately emetogenic chemotherapyJ J Rusthoven, D Osoba, C A Butts, et al.
Cancer Chemotherapy and Pharmacology|December 3, 2005
A semimechanistic-physiologic population pharmacokinetic/pharmacodynamic model for neutropenia following pemetrexed therapyJane E Latz, Mats O Karlsson, James J Rusthoven, et al.
Cancer Chemotherapy and Pharmacology|December 3, 2005
Clinical application of a semimechanistic-physiologic population PK/PD model for neutropenia following pemetrexed therapyJane E Latz, James J Rusthoven, Mats O Karlsson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Multitargeted antifolate LY231514 as first-line chemotherapy for patients with advanced non-small-cell lung cancer: A phase II study. National Cancer Institute of Canada Clinical Trials GroupJ J Rusthoven, E Eisenhauer, C Butts, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|August 1, 1993
Impact of chemotherapy-associated nausea and vomiting on patients' functional status and on costs: survey of five Canadian centresB J O'Brien, J Rusthoven, A Rocchi, et al.
Cancer|July 27, 2004
Adapting the Lung Cancer Symptom Scale (LCSS) to mesothelioma: using the LCSS-Meso conceptual model for validationPatricia J Hollen, Richard J Gralla, Astra M Liepa, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 7, 2005
Measuring quality of life in patients with pleural mesothelioma using a modified version of the Lung Cancer Symptom Scale (LCSS): psychometric properties of the LCSS-MesoPatricia J Hollen, Richard J Gralla, Astra M Liepa, et al.
Archives of Internal Medicine|July 1, 1988
Varicella-zoster infection in adult cancer patients. A population studyJ J Rusthoven, P Ahlgren, T Elhakim, et al.
International Journal of Antimicrobial Agents|May 1, 1997
Consensus on the use of neutrophil-stimulating hematopoietic growth factors in clinical practice: an international viewpointJ J Rusthoven, E G de Vries, D C Dale, et al.
Pageof 7